ALSO NOTED: ESC therapies in race to the clinic; Ultraviolet light used to target tumors; Scientists find chemical trigger to P

Stem Cell Research

Researchers at Geron and Advanced Cell Technology are jockeying to begin the first human clinical trials of embryonic stem cell therapies. Geron plans to file for regulatory approval by the end of this year, with ACT saying it will file its application by the middle of next year. Report

Orthopedic researchers at Jefferson Medical College have for the first time found stem cells in the intervertebral discs of the human spine, suggesting that such cells might someday be used to help repair degenerating discs and remedy lower back and neck pain. Release

According to a new study published in Circulation Research, University of Missouri-Columbia researchers say that a muscular dystrophy patient should be able to maintain a normal lifestyle if only 50 percent of the cells of their heart are healthy. Release

India's first clinical research facility for stem cells and regenerative medicine will be opened in Hyderabad by the Centre for Cellular and Molecular Biology and Nizam's Institute of Medical Sciences. Report

Carnegie Mellon University's Stefan F. Zappe is using adult neural stem cells to develop a new stem cell-based drug delivery therapy that may ultimately help treat a variety of inherited genetic disorders like Hunter syndrome. Release

Cancer Research

Colin Self and Stephen Thompson of Newcastle University have developed a technique that uses ultraviolet light to activate antibodies in a targeted attack on tumors. Report

A team of scientists at Albert Einstein College of Medicine of Yeshiva University in New York City say that knocking out the virus responsible for a number of cancers could be the most effective approach in preventing the disease. Both liver and cervical cancer are caused by viruses. And the scientists have been developing radioimmunotherapy to kill the viruses. Report

VIB scientists connected to the Katholieke Universiteit Leuven, in collaboration with the Flemish biotech company ThromboGenics, have been studying the anti-cancer action of anti-PLGF. Release

U.S. researchers have found a mechanism to predict survival in women aged 65 and older with early stage lung cancer.  The new study, published on Thursday in the medical journal Cancer Research, links high levels of aromatase, an enzyme that makes estrogen from another hormone called androgen, to a more aggressive and lethal form of the cancer. Release

A drug-- 2ME2--that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer, in particular the spread of breast cancer. Urszula Iwaniec, an assistant professor in the Department of Nutrition and Exercise Sciences at OSU, is the one of the authors of the study. Release

Genetics

The genome of the Abyssinian cat has been decoded, which will help advance research on some 200 human illnesses. Report

Shared genome data has been used to confirm that the SORL1 gene is linked to Alzheimer's. Report

UK scientists have discovered a genetic marker that may increase a person's susceptibility to rheumatoid arthritis. That work may highlight new targets for RA. Report

Genes linked to fruit fly sensitivity to alcohol may shed light on human drinking behavior. Report 

New research published in the journal Nature revealed more than 50 genomic regions that are frequently gained or lost in lung adenocarcinoma, the most common type of lung cancer in the United States. Release

More Research

Scientists have discovered that the tuberculosis drug D-cycloserine can alleviate anxiety and counter fear when used in a combination therapy. Report

Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease--a "breakthrough" finding that could pave the way for new, far more effective therapies. Release

The unexplained pain experienced by patients with fibromyalgia is the result of a mismatch between sensory and motor systems, new research suggests. Release 

British scientists say the nAG protein plays a critical role in spurring limb regeneration in newts, a discovery that could help advance the field of tissue regeneration. Report

A cold sore virus appears to be linked to Alzheimer's disease, a finding that could assist researchers looking for a vaccine to counter the threat. Report

Alzheimer's disease may progress more rapidly in people with high blood pressure or a form of irregular heartbeat, atrial fibrillation, according to results of a Johns Hopkins study published in Neurology. Release

Duke University Medical Center researchers have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer's disease. Release

Northwestern University researchers have shown that nanodiamonds are very effective at delivering chemotherapy drugs to cells without the negative effects associated with current drug delivery agents. Release

Suggested Articles

Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.

A PureTech startup is developing an immune-responsive hydrogel that releases a corticosteroid into arthritic joints based on their level of inflammation.

A trial of a retinal implant built from embryonic stem cells produced encouraging results in patients with dry age-related macular degeneration.